The United States represents a major contributor to the smart drug delivery system market, driven by advanced healthcare infrastructure, high adoption of connected medical devices, and the growing prevalence of chronic diseases such as diabetes and cardiovascular disorders. Increasing investments in digital health technologies and strong focus on patient-centered care continue to support the...